Status
Conditions
Treatments
About
The study is designed as a multicenter prospective trial of BTPNA for the diagnosis of peripheral pulmonary lesions in the real world. The purpose of the study is to evaluate the safety and effectiveness of BTPNA and to explore the factors of diagnosis rate.
Full description
The study will be conducted at about 10 clinical centers. Patients will be first screened, and only after meeting all the selection criteria, not meeting any exclusion criteria, and signing the informed consent, could they be enrolled in the group to receive BTPNA to sample the target lesions. The primary endpoint is the diagnostic yield of BTPNA. The secondary endpoints include the success rate of navigation, the operation time of the bronchoscope and so on.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
There are currently no registered sites for this trial.
Central trial contact
Jiayuan Sun, MD, PhD; Jiayuan Sun, MD, PhD
Start date
Dec 23, 2021 • 3 years ago
End date
Dec 30, 2023 • 1 year and 3 months ago
Today
Apr 05, 2025
Lead Sponsor
Collaborating Sponsors
Shandong Public Health Clinical Center
Xi 'an International Medical Center Hospital
Emergency General Hospital
Second Affiliated Hospital of Guangzhou Medical University
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal